PN Update

March 11, 2026

News, Information, and Educational Offerings From APA

Trump Spoke on Autism. Doctors Listened.

In the months after President Donald Trump discussed the alleged risks of acetaminophen and benefits of leucovorin as the medications related to autism, the prescribing of acetaminophen for pregnant women and leucovorin for children changed—dramatically.

Leucovorin Gets FDA Nod—Not for Autism

Months after first teasing leucovorin’s potential for treating autism, the FDA has approved the medication for a new indication: cerebral folate deficiency due to a mutation in folate receptor 1, a rare genetic condition believed to affect about one in 1 million individuals.

CLINICAL CORNER

PETRUSHKA Tool Works With Patients to Pick the Right Antidepressant

Journalists in War Zones Report High Lifetime Risk of Psychiatric Disorders

ANNUAL MEETING

Join the Foundation Gala’s DB Challenge

Join the APA Foundation’s Gala on May 18, 7:30 p.m. PT and you might help contribute to a cause close to your heart. The district branch with the highest percentage of Gala attendees will win a $10,000 donation to the charity of their choice! Tickets purchased for family and friends count toward the total. Gather your colleagues and enjoy dancing, dining, a silent auction, and more.

BUY TICKETS →

Opening Session With Dr. Sanjay Gupta

Among other topics, the neurosurgeon, bestselling author, and Emmy Award–winning medical correspondent will discuss the five key pillars for brain health—and how they map directly onto evidence-based psychiatric care and prevention.

GENERAL NEWS

Protect Patients From ‘Fail First’ Therapy

Step therapy is a harmful medical protocol whereby insurers require patients to try and then fail certain medications before agreeing to cover the initial prescribed therapy. Urge your representative and senators to support the Safe Step Act (H.R. 5509/S.2903), which requires health insurance companies to provide clear exemptions to step therapy policies and expedite their approval.

TAKE ACTION →

SAMHSA Announces $69M in SMI Grants

The Substance Abuse and Mental Health Services Administration is providing $69.1 million to expand services for individuals with serious mental illness and strengthen suicide prevention efforts. Funding will support the Children’s Mental Health Initiative, the Zero Suicide framework, and assisted outpatient treatment programs. Applications are due by April 20, 2026.

LEARN MORE AND APPLY →

H.R. 1 and Federal Loan Limits

Proposed federal loan caps under H.R. 1 could make medical education less accessible and further strain the psychiatric workforce. APA has developed an issue brief to inform psychiatrists and trainees about the proposed changes to federal student loans and their potential impact on medical education and the future workforce.

DOWNLOAD ISSUE BRIEF →

Updated SUD Record Protections in Effect

As of February 16, changes to 42 CFR Part 2—federal confidentiality protections for substance use disorder (SUD) treatment records—have fully gone into effect and are being enforced. Announced in February 2024, the changes align 42 CFR Part 2 more closely with HIPAA.

LEARN MORE →

Become a Residents’ Journal Editor

The AJP—Residents’ Journal is accepting applications for its 2026-2027 Editorial Board. Positions include associate editors, deputy editors, and media editors. APA resident-fellow members are welcome to apply—but act fast: The deadline is this Sunday, March 15.

LEARN MORE AND APPLY →

Renewal Window Closing

Keep your APA membership active and continue enjoying member-only benefits, including APA’s premier journals, CME opportunities, and career resources. Renew by March 31.

RENEW NOW →

JOBCENTRAL

Considering a Career Change?

Find your next role at APA JobCentral. Post a resume, set up job alerts, and find positions tailored just for you. Explore jobs by location, specialty, and keyword.

VISIT JOBCENTRAL →

NOW IN PSYCHIATRIC NEWS

Special Report: Pain as a Dual-Diagnosis Disorder

Rethinking Medication Intolerance in Psychiatry

Vast Majority of Those With FEP Don’t Access Coordinated Specialty Care

NOW IN THE AMERICAN JOURNAL OF PSYCHIATRY

A Universal Outcome Measure to Deliver on the Promises of Interventional Psychiatry

Advancing Brain Stimulation: Wearable Disposable Electrotherapy

Bipolar Disorder: An Update on Neurobiology and Treatment

March Residents’ Journal: Weaponizing Transphobia, Evolution of Psychotherapy Education, and More

NOW IN PSYCHIATRIC SERVICES

Uncovering Psychiatric Readmission Patterns to Guide Hospital Practices

Estimating ROI From Implementation of Individual Placement and Support

Characteristics of Youths Accessing In-Person and Virtual Peer Support Services

Bridging Systems for Transition-Age Youths With Co-Occurring Conditions

Copyright © 2026 {{ site_settings.company_name }}. All rights reserved.
{{ site_settings.company_street_address_1 }}, {{ site_settings.company_street_address_2 }}, {{ site_settings.company_city }}, {{ site_settings.company_state }}, {{ site_settings.company_zip }},{{ site_settings.company_country }}, {{ site_settings.company_phone }}

Unsubscribe Manage Preferences

Important information: You are receiving this correspondence because you previously requested to receive information via email. Please do not reply to this email, as we are unable to respond to messages sent to this address. You can send your comments or questions to PNUpdate@psych.org. The content of Psychiatric News does not necessarily reflect the views of APA or the editors. Unless so stated, neither Psychiatric News nor APA guarantees, warrants, or endorses information or advertising on this site. Clinical information is not peer reviewed and thus should be independently verified. Privacy Policy.